Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

TATAA Strengthens Quality Assurance Program

Published: Tuesday, May 21, 2013
Last Updated: Tuesday, May 21, 2013
Bookmark and Share
TATAA Biocenter expands offerings using AATI’s Fragment Analyzer™ to assess RNA quality in gene expression analysis.

TATAA Biocenter is strengthening its quality assurance program by introducing RNA quality assessment using Advanced Analytical Technologies, Inc. (“AATI”) Fragment Analyzer™ into its company’s Standard Operating Procedures (SOPs) for expression profiling. “As we are analysing more and more complex samples, including preserved materials such as formalin fixed and paraffin embedded tissues, soils and sewer samples, and other aggressive matrices, the quality of the extracted nucleic acids becomes critical for meaningful analysis. Much money can be saved by identifying problems at an early stage and either discarding poor quality samples or replacing them. With the Fragment Analyzer™ we can do this in high throughput, at acceptable cost and with greatest confidence”, says Dr. Mikael Kubista, founder and CEO of TATAA Biocenter.

Since the Fragment Analyzer™ product launch in early 2012, AATI has placed over 275 units worldwide and has quickly become the technology solution standard to which all others are measured within the rapidly expanding nucleic acids analysis industry.

“We couldn’t be more pleased to have an organization with the creditability of TATAA Biocenter added to our customer list. The Fragment Analyzer™ was designed and built with end-users first in mind,” said Dr. Steven Lasky, founder and CEO of AATI. “When we speak with potential users of the Fragment Analyzer™ we hear the same problem, they are frustrated with the existing competitive solutions; lack of ability to scale with their throughput, lack of reproducible resolution and lack of ability to perform multiple assessments on a single machine. Our proprietary technology allows us to streamline sample processing steps, analyze PCR and NGS library DNA fragments, total and messenger RNA, genomic DNA and DNA mutation detection assays all under one foot print. Together these attributes facilitate an enhanced return on capital for our customers.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More Than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

TATAA Biocenter and Strand Life Sciences Announce Strategic Partnership
TATAA Biocenter also to introduce Strand NGS in its popular NGS training courses.
Wednesday, June 24, 2015
Polar Distribution of MicroRNAs Discovered within Eukaryotic Cells
A plausible new mechanism contributing to asymmetric cell division.
Thursday, June 11, 2015
TATAA Partners with Qlucore
TATAA Biocenter introduces partnership with Qlucore to use Qlucore Omics Explorer in its Next Generation Sequencing courses and client services.
Monday, March 09, 2015
TATAA Biocenter Receives French Ministry Approval
Approval makes the Company even more competitive on the French market.
Tuesday, August 12, 2014
TATAA Biocenter Awarded for Best-in-Class Gene Expression Profiling Services
Numerous accreditations from diverse institutes and customer validations lend credibility to its educational programs.
Wednesday, August 21, 2013
TATAA Biocenter Introduces Ingenuity Systems iReport into qPCR Workflow
TATAA Biocenter, Europe´s leading provider of genomic services using quantitative real-time polymerase PCR (qPCR), is complementing its offerings in high-throughput gene expression profiling with Ingenuity® iReport™.
Wednesday, January 23, 2013
Correction of RT–qPCR Data for Genomic DNA-derived Signals with ValidPrime
Henrik Laurell et al propose a novel method (ValidPrime) that is more accurate than traditional RT(_) controls to test qPCR assays with respect to their sensitivity toward gDNA by compensating for DNA background.
Monday, January 09, 2012
Internship Opening with the Edu-GLIA project
Through the Initial Training Network (ITN) funded by the European Commission under the Seventh Framework Programme (FP7) TATAA Biocenter has been awarded early stage research positions within the Edu-GLIA project.
Monday, October 19, 2009
TATAA Biocenter Scientists Pioneer 3-Way Expression Profiling
A TATAA Biocenter researcher has performed a 3-way expression profiling study of the metabolism of Saccharomyces cerevisiae also called baker’s yeast.
Friday, April 25, 2008
TATAA Biocenter Establishes Centre in Prague, Czech Republic
TATAA Biocenter in Prague will offer full range of real-time PCR services including high throughput real-time PCR analysis and contract research.
Monday, April 23, 2007
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Revolutionary Technologies Developed to Improve Outcomes for Lung Cancer Patients
Breath test to detect lung cancer brings oxygen directly to the wound.
NIH Supports New Studies to Find Alzheimer’s Biomarkers in Down Syndrome
Initiative will track dementia onset, progress in Down syndrome volunteers.
Dementia Linked to Deficient DNA Repair
Mutant forms of breast cancer factor 1 (BRCA1) are associated with breast and ovarian cancers but according to new findings, in the brain the normal BRCA1 gene product may also be linked to Alzheimer’s disease.
Using Drug-Susceptible Parasites to Fight Drug Resistance
Researchers at the University of Georgia have developed a model for evaluating a potential new strategy in the fight against drug-resistant diseases.
Boosting Breast Cancer Treatment
To more efficiently treat breast cancer, scientists have been researching molecules that selectively bind to cancer cells and deliver a substance that can kill the tumor cells, for several years.
New Gene Map Reveals Cancer’s Achilles’ Heel
Team of researchers switches off almost 18,000 genes
New Discovery Sheds Light on Disease Risk
Gaps between genes interact to influence the risk of acquiring disease.
How Cells ‘Climb’ to Build Fruit Fly Tracheas
Mipp1 protein helps cells sprout “fingers” for gripping.
Research Finding Could Lead to Targeted Therapies for IBD
Findings published online in Cell Reports.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos